欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号NL/H/4551/002
药品名称Atosiban Accord 37.5 mg/5 ml concentrate for solution for infusion
活性成分
    • ATOSIBAN ACETATE 7.5 mg/ml
剂型SOLUTION FOR INJECTION IN PRE-FILLED PEN
上市许可持有人Accord Healthcare Limited Sage house, 319 Pinner Road, North Harrow, Middlesex HA1 4HF United Kingdom
参考成员国 - 产品名称Netherlands (NL)
Atosiban Accord 6,75 mg/0,9 ml oplossing voor injectie in een voorgevulde spuit
互认成员国 - 产品名称
    • United Kingdom (Northern Ireland) (XI)
      Atosiban Accord 37.5 mg/5 ml concentrate for solution for infusion
    • Germany (DE)
      Atosiban Accord 6,75 mg/0,9 ml Injektionslösung in einer Fertigspritze
    • Denmark (DK)
    • Austria (AT)
      Atosiban Accord 6,75 mg/0,9 ml Injektionslösung in einer Fertigspritze
    • France (FR)
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Sweden (SE)
    • Norway (NO)
    • Finland (FI)
    • Poland (PL)
      Atosiban Accord
    • Lithuania (LT)
      Atosiban Accord 6,75mg/0,9ml injekcinis tirpalas užpildytame švirkšte
许可日期2018/06/07
最近更新日期2024/04/02
药物ATC编码
    • G02CX01 atosiban
申请类型
  • TypeLevel1：[not specified]
  • TypeLevel2：[not specified]
  • TypeLevel3：[not specified]
  • TypeLevel4：[not specified]
  • TypeLevel5：[not specified]
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase